Human Embryonic Stem Cell (hESC) Market Report – Research, Industry Analysis Reports and Market Demands

Global Human Embryonic Stem Cell (hESC) Market Size, Status and Forecast 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
- 1.4.1 Global Human Embryonic Stem Cell (hESC) Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Totipotent Stem Cell
- 1.4.3 Pluripotent Stem Cell
- 1.4.4 Unipotent Stem Cell
1.5 Market by Application
- 1.5.1 Global Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2025)
- 1.5.2 Research
- 1.5.3 Clinical Trials
- 1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends

2.1 Human Embryonic Stem Cell (hESC) Market Size
2.2 Human Embryonic Stem Cell (hESC) Growth Trends by Regions
- 2.2.1 Human Embryonic Stem Cell (hESC) Market Size by Regions (2014-2025)
- 2.2.2 Human Embryonic Stem Cell (hESC) Market Share by Regions (2014-2019)
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Human Embryonic Stem Cell (hESC) Market Size by Manufacturers
- 3.1.1 Global Human Embryonic Stem Cell (hESC) Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Human Embryonic Stem Cell (hESC) Market Concentration Ratio (CR5 and HHI)
3.2 Human Embryonic Stem Cell (hESC) Key Players Head office and Area Served
3.3 Key Players Human Embryonic Stem Cell (hESC) Product/Solution/Service
3.4 Date of Enter into Human Embryonic Stem Cell (hESC) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019)
4.2 Global Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019)

5 United States

5.1 United States Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
5.2 Human Embryonic Stem Cell (hESC) Key Players in United States
5.3 United States Human Embryonic Stem Cell (hESC) Market Size by Type
5.4 United States Human Embryonic Stem Cell (hESC) Market Size by Application

6 Europe

6.1 Europe Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
6.2 Human Embryonic Stem Cell (hESC) Key Players in Europe
6.3 Europe Human Embryonic Stem Cell (hESC) Market Size by Type
6.4 Europe Human Embryonic Stem Cell (hESC) Market Size by Application

7 China

7.1 China Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
7.2 Human Embryonic Stem Cell (hESC) Key Players in China
7.3 China Human Embryonic Stem Cell (hESC) Market Size by Type
7.4 China Human Embryonic Stem Cell (hESC) Market Size by Application

8 Japan

8.1 Japan Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
8.2 Human Embryonic Stem Cell (hESC) Key Players in Japan
8.3 Japan Human Embryonic Stem Cell (hESC) Market Size by Type
8.4 Japan Human Embryonic Stem Cell (hESC) Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
9.2 Human Embryonic Stem Cell (hESC) Key Players in Southeast Asia
9.3 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Type
9.4 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Application

10 India

10.1 India Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
10.2 Human Embryonic Stem Cell (hESC) Key Players in India
10.3 India Human Embryonic Stem Cell (hESC) Market Size by Type
10.4 India Human Embryonic Stem Cell (hESC) Market Size by Application

11 Central & South America

11.1 Central & South America Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
11.2 Human Embryonic Stem Cell (hESC) Key Players in Central & South America
11.3 Central & South America Human Embryonic Stem Cell (hESC) Market Size by Type
11.4 Central & South America Human Embryonic Stem Cell (hESC) Market Size by Application

12 International Players Profiles

13 Market Forecast 2019-2025

13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
  - 15.1.1.1 Research Programs/Design
  - 15.1.1.2 Market Size Estimation
  - 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
  - 15.1.2.1 Secondary Sources
  - 15.1.2.2 Primary Sources
15.2 Disclaimer

Description

Human embryonic stem cell research has emerged as an important
platform for the understanding and treatment of pediatric diseases.
From its inception, however, it has raised ethical concerns based
not on the use of stem cells themselves but on objections to the source
of the cells—specifically, the destruction of preimplantation human
embryos. Despite differences in public opinion on this issue, a large
majority of the public supports continued research using embryonic
stem cells.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
In 2018, the global Human Embryonic Stem Cell (hESC) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Human Embryonic Stem Cell (hESC) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Embryonic Stem Cell (hESC) development in United States, Europe and China.

The key players covered in this study
Astellas Institute of Regenerative Medicine (US)
Asterias Biotherapeutics, Inc. (US)
BD Biosciences (US)
Cell Cure Neurosciences Ltd. (Israel)
Cellular Dynamics International (US)
GE Healthcare (UK)
MilliporeSigma (US)
PerkinElmer, Inc. (US)
Reliance Life Sciences Ltd. (India)
Research & Diagnostics Systems, Inc. (US)
SABiosciences Corp. (US)
STEMCELL Technologies, Inc. (Canada)
Stemina Biomarker Discovery, Inc. (US)
Takara Bio, Inc. (Japan)
TATAA Biocenter AB (Sweden)
Thermo Fisher Scientific, Inc. (US)
UK Stem Cell Bank (UK)
ViaCyte, Inc. (US)
Vitrolife AB (Sweden)

Market segment by Type, the product can be split into
Totipotent Stem Cell
Pluripotent Stem Cell
Unipotent Stem Cell

Market segment by Application, split into
Research
Clinical Trials
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human Embryonic Stem Cell (hESC) status, future forecast, growth opportunity, key market and key players.
To present the Human Embryonic Stem Cell (hESC) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Embryonic Stem Cell (hESC) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.